In group A4 (eGFR < 30 mL/min/1.73 m2), including patients with cardiogenic shock, Killip class III/IV, non-STEMI (NSTEMI), hypertension, DM, previous MI, previous PCI, previous coronary artery bypass graft (CABG), previous HF, previous CVA, LM IRA and treated vessel, ACC/AHA type C lesion, ≥3-vessel disease, everolimus-eluting stent as a deployed stent and atorvastatin as a discharge medication, the mean values of peak troponin-I, NT-ProBNP, high-sensitivity C-reactive protein (hs-CRP), blood glucose and stent length and mean number of deployed stents were highest. This evidence concerns the gene CRP and Hypertension.